Acumen Pharmaceuticals, Inc. (ABOS)
↓ Download CSVKey ratios (FY2025)
-172.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$123.83M | -$114.02M | -$61.14M | -$45.24M | -$19.58M | -$7.91M | — |
| Net Income | -$121.33M | -$102.33M | -$52.37M | -$42.86M | -$100.61M | -$7.33M | — |
| EPS (Diluted) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | — | — |
| Total Assets | $122.83M | $238.99M | $310.12M | $196.59M | $230.33M | $44.43M | — |
| Total Liabilities | $52.40M | $57.18M | $43.15M | $7.81M | $5.15M | $6.37M | — |
| Shareholders' Equity | $70.43M | $181.82M | $266.97M | $188.78M | $225.18M | -$18.59M | -$11.42M |
| Cash & Equivalents | $53.99M | $35.63M | $66.89M | $130.10M | $122.16M | $43.78M | $6.55M |
| Operating Cash Flow | -$115.54M | -$86.22M | -$43.06M | -$35.15M | -$17.96M | -$7.45M | — |
| Capital Expenditures | $88.0K | $16.0K | $21.0K | $161.0K | $40.0K | — | — |
| Shares Outstanding | 60.58M | 60.09M | 57.91M | 41.03M | 40.47M | 419.1K | — |